| 标题 |
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology and Hepatology 作者:M. Javle; S. Roychowdhury; R. Kelley; S. Sadeghi; T. Macarulla; et al 出版日期:2021-08-03 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)